165 related articles for article (PubMed ID: 38658465)
1. Long-term quality of life of testicular cancer survivors differs according to applied adjuvant treatment and tumour type.
Heinzelbecker J; Kaßmann K; Ernst S; Meyer-Mabileau P; Germanyuk A; Zangana M; Wagenpfeil G; Ohlmann CH; Cohausz M; Stöckle M; Lehmann J
J Cancer Surviv; 2024 Apr; ():. PubMed ID: 38658465
[TBL] [Abstract][Full Text] [Related]
2. Quality-of-Life Analysis of the German Prospective Multicentre Trial of Single-cycle Adjuvant BEP Versus Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Tumours.
Flechtner HH; Fischer F; Albers P; Hartmann M; Siener R;
Eur Urol; 2016 Mar; 69(3):518-25. PubMed ID: 26620368
[TBL] [Abstract][Full Text] [Related]
3. Sexual function using the EORTC QLQ-TC26 in testicular cancer survivors: A multi-institutional, cross-sectional study.
Koyama J; Yamashita S; Kakimoto K; Uemura M; Kishida T; Kawai K; Nakamura T; Goto T; Osawa T; Nishimura K; Nonomura N; Nishiyama H; Shiraishi T; Ukimura O; Ogawa O; Shinohara N; Suzukamo Y; Ito A; Arai Y
Int J Urol; 2023 Nov; 30(11):1044-1050. PubMed ID: 37522577
[TBL] [Abstract][Full Text] [Related]
4. Health-Related Quality of Life in Testicular Cancer Survivors in Japan: A Multi-Institutional, Cross-Sectional Study Using the EORTC QLQ-TC26.
Yamashita S; Kakimoto K; Uemura M; Kishida T; Kawai K; Nakamura T; Goto T; Osawa T; Yamada S; Nishimura K; Nonomura N; Nishiyama H; Shiraishi T; Ukimura O; Ogawa O; Shinohara N; Suzukamo Y; Ito A; Arai Y
Urology; 2021 Oct; 156():173-180. PubMed ID: 33785401
[TBL] [Abstract][Full Text] [Related]
5. Quality of Life in NSCLC Survivors - A Multicenter Cross-Sectional Study.
Hechtner M; Eichler M; Wehler B; Buhl R; Sebastian M; Stratmann J; Schmidberger H; Gohrbandt B; Peuser J; Kortsik C; Nestle U; Wiesemann S; Wirtz H; Wehler T; Bals R; Blettner M; Singer S
J Thorac Oncol; 2019 Mar; 14(3):420-435. PubMed ID: 30508641
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal changes of health-related quality of life over 10 years in breast cancer patients treated with radiotherapy following breast-conserving surgery.
Gao Y; Rosas JC; Fink H; Behrens S; Chang-Claude J; Seibold P
Qual Life Res; 2023 Sep; 32(9):2639-2652. PubMed ID: 37093543
[TBL] [Abstract][Full Text] [Related]
7. Association of financial toxicity with quality of life in testicular cancer survivors.
Nezu K; Yamashita S; Kakimoto K; Uemura M; Kishida T; Kawai K; Nakamura T; Goto T; Osawa T; Nishimura K; Nonomura N; Negoro H; Shiraishi T; Ukimura O; Ogawa O; Shinohara N; Suzukamo Y; Ito A; Arai Y
Int J Urol; 2022 Dec; 29(12):1526-1534. PubMed ID: 36102302
[TBL] [Abstract][Full Text] [Related]
8. Influence of achieved paternity on quality of life in testicular cancer survivors.
Stoehr B; Schachtner L; Pichler R; Holzner B; Giesinger J; Oberguggenberger A; Leonhartsberger N; Horninger W; Steiner H
BJU Int; 2013 Apr; 111(4 Pt B):E207-12. PubMed ID: 23107372
[TBL] [Abstract][Full Text] [Related]
9. Quality of life assessment in testicular non-seminomatous germ cell tumour survivors.
Pathak N; Raj A; Santhosh AP; Kumar S; Haresh KP; Singh P; Nayak B; Shamim SA; Seth A; Ray M; Kaushal S; Sahoo RK; Batra A
J Cancer Surviv; 2023 Jul; ():. PubMed ID: 37395935
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life among non-muscle-invasive bladder cancer survivors: a population-based study.
Jung A; Nielsen ME; Crandell JL; Palmer MH; Smith SK; Bryant AL; Mayer DK
BJU Int; 2020 Jan; 125(1):38-48. PubMed ID: 31381249
[TBL] [Abstract][Full Text] [Related]
11. Management of patients with low-stage nonseminomatous germ cell testicular cancer.
Stephenson AJ; Sheinfeld J
Curr Treat Options Oncol; 2005 Sep; 6(5):367-77. PubMed ID: 16107240
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-Induced Peripheral Neuropathy (CIPN) as a Predictor of Decreased Quality of Life in Testicular Germ Cell Tumor Survivors.
Orszaghova Z; Galikova D; Lesko P; Obertova J; Rejlekova K; Sycova-Mila Z; Palacka P; Kalavska K; Svetlovska D; Mladosievicova B; Mardiak J; Mego M; Chovanec M
Clin Genitourin Cancer; 2024 Jun; 22(3):102067. PubMed ID: 38555680
[TBL] [Abstract][Full Text] [Related]
13. Fertility, gonadal and sexual function in survivors of testicular cancer.
Huddart RA; Norman A; Moynihan C; Horwich A; Parker C; Nicholls E; Dearnaley DP
Br J Cancer; 2005 Jul; 93(2):200-7. PubMed ID: 15999104
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
[TBL] [Abstract][Full Text] [Related]
15. Management of patients with clinical stage I nonseminomatous testicular germ cell tumours: active surveillance versus primary chemotherapy versus nerve sparing retroperitoneal lymphadenectomy.
Heidenreich A; Pfister D
Arch Esp Urol; 2012 Mar; 65(2):215-26. PubMed ID: 22414450
[TBL] [Abstract][Full Text] [Related]
16. Comparative Effectiveness of Surveillance, Primary Chemotherapy, Radiotherapy and Retroperitoneal Lymph Node Dissection for the Management of Early Stage Testicular Germ Cell Tumors: A Systematic Review.
Pierorazio PM; Cheaib JG; Patel HD; Gupta M; Sharma R; Zhang A; Tema G; Bass EB
J Urol; 2021 Feb; 205(2):370-382. PubMed ID: 32915080
[TBL] [Abstract][Full Text] [Related]
17. Retroperitoneal lymphadenectomy and resection for testicular cancer: an update on best practice.
Heidenreich A; Pfister D
Ther Adv Urol; 2012 Aug; 4(4):187-205. PubMed ID: 22852029
[TBL] [Abstract][Full Text] [Related]
18. Retroperitoneal lymph node dissection as adjuvant therapy in the treatment of non-seminomatous testicular cancer.
Thijssens K; Vaneerdeweg W; Schrijvers D; Eyskens E; Van Oosterom A
Acta Chir Belg; 2003; 103(6):599-602. PubMed ID: 14743567
[TBL] [Abstract][Full Text] [Related]
19. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer.
Pearce SM; Golan S; Gorin MA; Luckenbaugh AN; Williams SB; Ward JF; Montgomery JS; Hafez KS; Weizer AZ; Pierorazio PM; Allaf ME; Eggener SE
Eur Urol; 2017 Mar; 71(3):476-482. PubMed ID: 27234998
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Patient-Reported Quality of Life of Anal Cancer Survivors Treated With Intensity Modulated Radiation Therapy and Concurrent Chemotherapy: Results From a Prospective Phase II Trial.
Joseph K; Balushi MA; Ghosh S; Stenson T; Abraham A; Elangovan A; Warkentin H; Paulson K; Tankel K; Usmani N; Severin D; Schiller D; Wong C; Mulder K; Doll C; King K; Nijjar T
Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):434-445. PubMed ID: 37148982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]